<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04759599</url>
  </required_header>
  <id_info>
    <org_study_id>MD 1-11-2020</org_study_id>
    <nct_id>NCT04759599</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Narrow Focus (F1) Versus Wide Focus (F3) of Shock Wave Lithotripsy (SWL) for Renal Calculi</brief_title>
  <official_title>Which is Better: Narrow vs. Wide Focus for Shock Wave Lithotripsy of Renal Stones</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Benha University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Benha University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare the narrow focus (F1) versus the wide focus (F3) in terms of the&#xD;
      efficacy of Shock Wave Lithotripsy (SWL) in the management of renal calculi 1-2 cm and their&#xD;
      injurious effect on the kidney.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recently, some Shock Wave Lithotripsy (SWL) devices have been announced in the market with a&#xD;
      different focus points. One early experimental study found that stone disintegration is&#xD;
      better with small focusing points than larger focusing points. Nevertheless, these findings,&#xD;
      in terms of the efficacy of stone disintegration, need to be validated in-vivo. Furthermore,&#xD;
      the effect of focal size on renal injury during SWL need to be studied as well. Therefore,&#xD;
      the objectives of this study are to compare the effect of using the narrow focus of 2mm (F1)&#xD;
      versus the wide focus of 8 mm (F3) on the Stone Free Rate (SFR) following SWL for renal&#xD;
      stones 1-2cm and estimating renal injury effect of F1 vs. F3 by urinary renal injury markers&#xD;
      such as neutrophil gelatinase-associated lipocalin (NGAL) for assessment of proximal and&#xD;
      distal renal tubules injury &amp; Kidney Injury Molecule-1 (KIM-1) for assessment of proximal&#xD;
      renal tubules injury).&#xD;
&#xD;
      The SWL device:&#xD;
&#xD;
      Lithotripter type: Piezo Lith3000 plus ( from Richard Wolf, Germany.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Anticipated">September 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of efficacy of Shock Wave Lithotripsy (SWL) by calculation of the percentage (%) of stone free</measure>
    <time_frame>1 year</time_frame>
    <description>Assessment of efficacy of Shock Wave Lithotripsy (SWL) and its success by calculation of stone free (%) following each session with a maximum of 3 Shock Wave Lithotripsy (SWL) sessions, 2 weeks a part, using pelvi-abdominal Ultrasound (US) and Kidney-Ureter-Bladder (KUB) and the presence of significant residual stone &gt;4 mm will be considered &quot;non-stone free&quot; and the final stone free status (%) will be calculated at one month following the last session of Shock Wave Lithotripsy (SWL).&#xD;
Shock Wave Lithotripsy (SWL) failure will be defined as failure to reach stone free status (%) one month after 3rd session.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of the degree of renal injury using renal injury markers</measure>
    <time_frame>1 year</time_frame>
    <description>Assessment of the degree of renal injury using renal injury markers as follow:&#xD;
- Urine analysis for neutrophil gelatinase-associated lipocalin (NGAL) (ng/dL) &amp; Kidney Injury Molecule 1 (KIM-1) (ng/dL) will be measured measured with enzyme-linked immunosorbent assay (ELISA) method before, 2 hours after and 72 hours after the 1st Shock Wave Lithotripsy (SWL) session.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of the presence of peri-renal hematoma</measure>
    <time_frame>1 year</time_frame>
    <description>Assessment of the presence of peri-renal hematoma will be conducted as follow:&#xD;
- Ultrasonography (US) will be done 24 hours after Shock Wave Lithotripsy (SWL) session to search for the presence of peri-renal hematoma and measure its size (cc).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of the changes in renal cortical thickness</measure>
    <time_frame>1 year</time_frame>
    <description>Changes in the renal cortical thickness will be assessed as follow:&#xD;
- Ultrasonography (US) will be done before and after 6 months post Shock Wave Lithotripsy (SWL) for assessment of renal cortical thickness (mm) and the pre- and post-SWL measurements will be compared</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of the changes in the Renal Resistive Index (RRI)</measure>
    <time_frame>1 year</time_frame>
    <description>Renal Resistive Index (RRI) will be measured in the arcuate arteries using the following formula &quot;RRI can be calculated as (peak systolic velocity - end diastolic velocity)/peak systolic velocity&quot; before and 24 hours after Shock Wave Lithotripsy (SWL) using Doppler Ultrasound and changes will be recorded</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Renal Stone</condition>
  <condition>Treatment Side Effects</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 1 will undergo Shock Wave Lithotripsy (SWL) with focal size 2mm (F1), and 3000 shocks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 2 will undergo Shock Wave Lithotripsy (SWL) with focal size 8mm (F3), and 3000 shocks</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Shock Wave Lithotripsy (SWL)</intervention_name>
    <description>Shock Wave Lithotripsy (SWL) with focal size 2mm (F1), and 3000 shocks or Shock Wave Lithotripsy (SWL) with focal size 8mm (F3), and 3000 shocks</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adult patients (&gt;18years old) with 1-2 cm single renal stone.&#xD;
&#xD;
          2. Normal functioning kidney.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnancy.&#xD;
&#xD;
          2. Bleeding diatheses.&#xD;
&#xD;
          3. Radiolucent stones.&#xD;
&#xD;
          4. Radio-opaque stones with Hounsfield Unit (HU) &gt; 1200&#xD;
&#xD;
          5. Patients with a pacemaker.&#xD;
&#xD;
          6. Active Urinary Tract Infection (UTI).&#xD;
&#xD;
          7. Severe skeletal malformations.&#xD;
&#xD;
          8. Morbid obesity with Body Mass Index (BMI) ≥40 kg/m2.&#xD;
&#xD;
          9. Renal artery aneurysm at the same site of the stone.&#xD;
&#xD;
         10. Anatomical obstruction distal to the stone.&#xD;
&#xD;
         11. Patients with renal impairment with serum creatinine &gt; 1.2 mg/dL.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yasser Noureldin, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Benha University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ahmed Abdelbaky, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Benha University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Walid Ibrahim, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Benha University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ezzat Elnahife, MD</last_name>
    <role>Study Director</role>
    <affiliation>Benha University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Salah El Hamshary, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Benha University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yasser Noureldin, MD, PhD</last_name>
    <phone>01225352115</phone>
    <email>dryasser.noor@fmed.bu.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ezzat Elnahife, MD</last_name>
    <phone>01008117250</phone>
    <email>ezatsaid14@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Faculty of Medicine, Benha University</name>
      <address>
        <city>Banhā</city>
        <state>Kalyobiya</state>
        <zip>13518</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yasser Noureldin, MD, PhD</last_name>
      <phone>01225352115</phone>
      <email>dryasser.noor@fmed.bu.edu.eg</email>
    </contact>
    <contact_backup>
      <last_name>Ezzat Elnahife, MD</last_name>
      <phone>01008117250</phone>
      <email>ezatsaid14@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Turney BW, Reynard JM, Noble JG, Keoghane SR. Trends in urological stone disease. BJU Int. 2012 Apr;109(7):1082-7. doi: 10.1111/j.1464-410X.2011.10495.x. Epub 2011 Aug 26.</citation>
    <PMID>21883851</PMID>
  </reference>
  <reference>
    <citation>Connors BA, Evan AP, Blomgren PM, Handa RK, Willis LR, Gao S. Effect of initial shock wave voltage on shock wave lithotripsy-induced lesion size during step-wise voltage ramping. BJU Int. 2009 Jan;103(1):104-7. doi: 10.1111/j.1464-410X.2008.07922.x. Epub 2008 Aug 1.</citation>
    <PMID>18680494</PMID>
  </reference>
  <reference>
    <citation>Devarajan P. Biomarkers for the early detection of acute kidney injury. Curr Opin Pediatr. 2011 Apr;23(2):194-200. doi: 10.1097/MOP.0b013e328343f4dd. Review.</citation>
    <PMID>21252674</PMID>
  </reference>
  <reference>
    <citation>Veser J, Jahrreiss V, Seitz C, Özsoy M. The effect of focus size and intensity on stone fragmentation in SWL on a piezoelectric lithotripter. World J Urol. 2020 Oct;38(10):2645-2650. doi: 10.1007/s00345-019-03069-y. Epub 2020 Jan 10.</citation>
    <PMID>31925550</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 3, 2021</study_first_submitted>
  <study_first_submitted_qc>February 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2021</study_first_posted>
  <last_update_submitted>February 17, 2021</last_update_submitted>
  <last_update_submitted_qc>February 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Benha University</investigator_affiliation>
    <investigator_full_name>Yasser A. Noureldin</investigator_full_name>
    <investigator_title>Assistant Professor of Urology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

